-
Je něco špatně v tomto záznamu ?
Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review
KM. Raspovic, NC. Schaper, C. Gooday, A. Bal, R. Bem, A. Chhabra, M. Hastings, C. Holmes, NL. Petrova, MG. Santini Araujo, E. Senneville, DK. Wukich
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu systematický přehled, časopisecké články
PubMed
37179484
DOI
10.1002/dmrr.3653
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 1. typu * MeSH
- diabetes mellitus 2. typu * MeSH
- diabetická noha * diagnóza etiologie terapie MeSH
- lidé MeSH
- neuropatická artropatie * komplikace diagnóza MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
BACKGROUND: There are uncertainties regarding the diagnostic criteria, optimal treatment methods, interventions, monitoring and determination of remission of Charcot neuro-osteoarthropathy (CNO) of the foot and ankle in people with diabetes mellitus (DM). The aims of this systematic review are to investigate the evidence for the diagnosis and subsequent treatment, to clarify the objective methods for determining remission and to evaluate the evidence for the prevention of re-activation in people with CNO, DM and intact skin. METHODS: We performed a systematic review based on clinical questions in the following categories: Diagnosis, Treatment, Identification of Remission and Prevention of Re-Activation in people with CNO, DM and intact skin. Included controlled studies were assessed for methodological quality and key data from all studies were extracted. RESULTS: We identified 37 studies for inclusion in this systematic review. Fourteen retrospective and observational studies relevant to the diagnosis of active CNO with respect to clinical examination, imaging and blood laboratory tests in patients with DM and intact skin were included. We identified 18 studies relevant to the treatment of active CNO. These studies included those focused on offloading (total contact cast, removable/non-removable knee high devices), medical treatment and surgical treatment in the setting of active CNO. Five observational studies were identified regarding the identification of remission in patients who had been treated for active CNO. We did not identify any studies that met our inclusion criteria for the prevention of re-activation in patients with DM and intact skin who had been previously treated for active CNO and were in remission. CONCLUSIONS: There is a paucity of high-quality data on the diagnosis, treatment, and prognosis of active CNO in people with DM and intact skin. Further research is warranted to address the issues surrounding this complex disease.
Department of Diabetes Diabetic Foot Clinic King's College Hospital NHS Foundation Trust London UK
Department of Orthopaedic Surgery University of Texas Southwestern Medical Center Dallas Texas USA
Department of Radiology University of Texas Southwestern Medical Center Dallas Texas USA
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Division of Endocrinology MUMC CARIM and CAPHRI Institute Maastricht The Netherlands
Gustave Dron Hospital Tourcoing Univ Lille Lille France
Italian Hospital of Buenos Aires Buenos Aires Argentina
Program in Physical Therapy Washington University School of Medicine St Louis Missouri USA
Secretary International Association of Diabetic Foot Surgeons Mumbai India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007023
- 003
- CZ-PrNML
- 005
- 20240423155651.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/dmrr.3653 $2 doi
- 035 __
- $a (PubMed)37179484
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Raspovic, Katherine M $u Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA $1 https://orcid.org/0000000178486854
- 245 10
- $a Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review / $c KM. Raspovic, NC. Schaper, C. Gooday, A. Bal, R. Bem, A. Chhabra, M. Hastings, C. Holmes, NL. Petrova, MG. Santini Araujo, E. Senneville, DK. Wukich
- 520 9_
- $a BACKGROUND: There are uncertainties regarding the diagnostic criteria, optimal treatment methods, interventions, monitoring and determination of remission of Charcot neuro-osteoarthropathy (CNO) of the foot and ankle in people with diabetes mellitus (DM). The aims of this systematic review are to investigate the evidence for the diagnosis and subsequent treatment, to clarify the objective methods for determining remission and to evaluate the evidence for the prevention of re-activation in people with CNO, DM and intact skin. METHODS: We performed a systematic review based on clinical questions in the following categories: Diagnosis, Treatment, Identification of Remission and Prevention of Re-Activation in people with CNO, DM and intact skin. Included controlled studies were assessed for methodological quality and key data from all studies were extracted. RESULTS: We identified 37 studies for inclusion in this systematic review. Fourteen retrospective and observational studies relevant to the diagnosis of active CNO with respect to clinical examination, imaging and blood laboratory tests in patients with DM and intact skin were included. We identified 18 studies relevant to the treatment of active CNO. These studies included those focused on offloading (total contact cast, removable/non-removable knee high devices), medical treatment and surgical treatment in the setting of active CNO. Five observational studies were identified regarding the identification of remission in patients who had been treated for active CNO. We did not identify any studies that met our inclusion criteria for the prevention of re-activation in patients with DM and intact skin who had been previously treated for active CNO and were in remission. CONCLUSIONS: There is a paucity of high-quality data on the diagnosis, treatment, and prognosis of active CNO in people with DM and intact skin. Further research is warranted to address the issues surrounding this complex disease.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diabetická noha $x diagnóza $x etiologie $x terapie $7 D017719
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a diabetes mellitus 1. typu $7 D003922
- 650 12
- $a diabetes mellitus 2. typu $7 D003924
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a neuropatická artropatie $x komplikace $x diagnóza $7 D001177
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Schaper, Nicolaas C $u Division of Endocrinology, MUMC+, CARIM and CAPHRI Institute, Maastricht, The Netherlands
- 700 1_
- $a Gooday, Catherine $u Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk, UK $1 https://orcid.org/0000000150266788
- 700 1_
- $a Bal, Arun $u Secretary, International Association of Diabetic Foot Surgeons, Mumbai, India
- 700 1_
- $a Bem, Robert $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Chhabra, Avneesh $u Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- 700 1_
- $a Hastings, Mary $u Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri, USA
- 700 1_
- $a Holmes, Crystal $u The Division of Metabolism, Endocrinology and Diabetes, The University of Michigan Medical School, Ann Arbor, Michigan, USA
- 700 1_
- $a Petrova, Nina L $u Department of Diabetes, Diabetic Foot Clinic, King's College Hospital NHS Foundation Trust, London, UK
- 700 1_
- $a Santini Araujo, Maria Gala $u Italian Hospital of Buenos Aires, Buenos Aires, Argentina $1 https://orcid.org/0000000251275827
- 700 1_
- $a Senneville, Eric $u Gustave Dron Hospital, Tourcoing, Univ-Lille, Lille, France $1 https://orcid.org/0000000257208908
- 700 1_
- $a Wukich, Dane K $u Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- 773 0_
- $w MED00005254 $t Diabetes/metabolism research and reviews $x 1520-7560 $g Roč. 40, č. 3 (2024), s. e3653
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37179484 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155647 $b ABA008
- 999 __
- $a ok $b bmc $g 2081183 $s 1216790
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 40 $c 3 $d e3653 $e 20230514 $i 1520-7560 $m Diabetes/metabolism research and reviews $n Diabetes Metab Res Rev $x MED00005254
- LZP __
- $a Pubmed-20240412